The current board of directors at Plus Therapeutics has a wide range of experiences in the medical and legal field. Many of the members are from esteemed universities such as UC Santa Barbara, UC Berkeley, and UCSF. The board also has members who have significant experience in the pharmaceutical industry, such as CEO's and Chief Scientific Officers. This experience gives the board a well-rounded perspective when it comes to making decisions for the company.
Alireza Mohammadi
Clinical Advisor
An van Es-Johansson
Director
Andrew Brenner
Scientific Advisor
Greg Petersen
Director
Howard Clowes
Director
John McKew
Scientific Advisor
Manish Aghi
Clinical Advisor
Michael Vogelbaum
Clinical Advisor
Nicholas Butowski
Clinical Advisor
Richard J. Hawkins
Chairman
Robert Lenk
Director
Russell Lonser
Clinical Advisor
Vladimir P. Torchili...
Scientific Advisor
View all